Paul J Hastings - Net Worth and Insider Trading
Paul J Hastings Net Worth
The estimated net worth of Paul J Hastings is at least $1 Million dollars as of 2024-11-13. Paul J Hastings is the CEO of Nkarta Inc and owns about 240,737 shares of Nkarta Inc (NKTX) stock worth over $731,840. Paul J Hastings is the Chairman & CEO of OncoMed Pharmaceuticals Inc and owns about 401,028 shares of OncoMed Pharmaceuticals Inc (OMED) stock worth over $356,915. Paul J Hastings is also the Director of Pacira BioSciences Inc and owns about 12,724 shares of Pacira BioSciences Inc (PCRX) stock worth over $213,890. Besides these, Paul J Hastings also holds Relypsa Inc (RLYP) . Details can be seen in Paul J Hastings's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul J Hastings has not made any transactions after 2024-06-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul J Hastings
Paul J Hastings Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul J Hastings owns 6 companies in total, including Nkarta Inc (NKTX) , Pacira BioSciences Inc (PCRX) , and Protara Therapeutics Inc (TARA) among others .
Click here to see the complete history of Paul J Hastings’s form 4 insider trades.
Insider Ownership Summary of Paul J Hastings
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTX | Nkarta Inc | 2024-06-18 | director & See Remarks |
| PCRX | Pacira BioSciences Inc | 2024-06-13 | director |
| TARA | Protara Therapeutics Inc | 2016-10-18 | director |
 | | 2017-10-10 | Chairman & CEO |
| | 2016-09-01 | director |
| | 2005-04-29 | director & President & CEO |
Paul J Hastings Latest Holdings Summary
Paul J Hastings currently owns a total of 4 stocks. Among these stocks, Paul J Hastings owns 240,737 shares of Nkarta Inc (NKTX) as of June 18, 2024, with a value of $731,840 and a weighting of 52.94%. Paul J Hastings owns 401,028 shares of OncoMed Pharmaceuticals Inc (OMED) as of October 10, 2017, with a value of $356,915 and a weighting of 25.82%. Paul J Hastings also owns 12,724 shares of Pacira BioSciences Inc (PCRX) as of June 13, 2024, with a value of $213,890 and a weighting of 15.47%. The other 1 stocks Relypsa Inc (RLYP) have a combined weighting of 5.77% among all his current holdings.
Latest Holdings of Paul J Hastings
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTX | Nkarta Inc | 2024-06-18 | 240,737 | 3.04 | 731,840 |
| OMED | OncoMed Pharmaceuticals Inc | 2017-10-10 | 401,028 | 0.89 | 356,915 |
| PCRX | Pacira BioSciences Inc | 2024-06-13 | 12,724 | 16.81 | 213,890 |
| RLYP | Relypsa Inc | 2016-06-07 | 2,495 | 31.99 | 79,815 |
Holding Weightings of Paul J Hastings
Paul J Hastings Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul J Hastings has made a total of 9 transactions in Nkarta Inc (NKTX) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Nkarta Inc is the sale of 1,770 shares on June 18, 2024, which brought Paul J Hastings around $9,912.
According to the SEC Form 4 filings, Paul J Hastings has made a total of 0 transactions in OncoMed Pharmaceuticals Inc (OMED) over the past 5 years. The most-recent trade in OncoMed Pharmaceuticals Inc is the sale of 1,398 shares on October 10, 2017, which brought Paul J Hastings around $5,928.
According to the SEC Form 4 filings, Paul J Hastings has made a total of 7 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Pacira BioSciences Inc is the sale of 880 shares on June 13, 2024, which brought Paul J Hastings around $24,974.
More details on Paul J Hastings's insider transactions can be found in the Insider Trading History of Paul J Hastings table.Insider Trading History of Paul J Hastings
- 1
Paul J Hastings Trading Performance
GuruFocus tracks the stock performance after each of Paul J Hastings's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul J Hastings is 23.56%. GuruFocus also compares Paul J Hastings's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul J Hastings within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul J Hastings's insider trading performs compared to the benchmark.
Performance of Paul J Hastings
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.98 | | | | | |
| Relative Return to S&P 500(%) | 3.91 | | | | | |
Paul J Hastings Ownership Network
Ownership Network List of Paul J Hastings
Ownership Network Relation of Paul J Hastings
Paul J Hastings Owned Company Details
What does Nkarta Inc do?
Who are the key executives at Nkarta Inc?
Paul J Hastings is the director & See Remarks of Nkarta Inc. Other key executives at Nkarta Inc include Chief Legal Officer Alicia J. Hager , Chief Medical Officer David Shook , and Sr. VP & Technical Operations Ralph Brandenberger .
Nkarta Inc (NKTX) Insider Trades Summary
Over the past 18 months, Paul J Hastings made 3 insider transaction in Nkarta Inc (NKTX) with a net sale of 13,171. Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 9,598 shares made by James Trager , a net sale of 9,378 shares made by Alicia J. Hager , and a net sale of 5,778 shares made by David Shook .
In summary, during the past 3 months, insiders sold 0 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 41,413 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,958,587 shares.
Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nkarta Inc Insider Transactions
Paul J Hastings Mailing Address
Above is the net worth, insider trading, and ownership report for Paul J Hastings. You might contact Paul J Hastings via mailing address: 61 Hartford Street, San Francisco Ca 94114.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
